Sipai Health Technology Co., Ltd. (00314) disclosed a share repurchase on 03 February 2026. A total of 1,656,000 shares were repurchased on the exchange, representing approximately 0.223% of the company’s then-existing issued shares (excluding treasury shares). The average purchase price was reported at HKD 2.7352 per share, bringing the total cost of the repurchase to HKD 4,529,460.

Following this transaction, the number of treasury shares rose to 23,522,600, while the issued shares (excluding treasury shares) stood at 742,055,514. The total number of shares remained at 765,578,114. According to the announcement, the share repurchase was conducted under a mandate granted on 20 June 2025, which authorized the repurchase of up to 75,022,471 shares.

Pursuant to the prevailing regulations, the issuer noted a moratorium period for any new share issuance or sale of treasury shares until 05 March 2026. The company confirmed that the repurchase was carried out in compliance with all applicable listing rules and regulatory requirements.